相关实验视频
Updated: Aug 15, 2026
07:07
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
12.4K
从2022年到2023年的文章将告知您的癌症实践:黑色素瘤
Georgia M Beasley1, Alicia M Terando2
1Department of Surgery, Duke University Medical Center, Durham, NC, USA. Georgia.beasley@duke.edu.
Annals of surgical oncology
|December 10, 2023
概括
系统疗法,包括免疫检查点抑制剂 (ICI) 和BRAF/MEK抑制剂,已经改变了晚期黑色素瘤的治疗方法. 最近的数据突出显示,ICI疗法测序和可切除疾病的新辅助方法改善了存活率.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 黑色素瘤治疗方法
背景情况:
- 先进的黑色素瘤管理已经被免疫检查点抑制剂 (ICI) 和BRAF/MEK抑制剂疗法彻底改变.
- 不断发展的治疗模式包括辅助,新辅助和组合策略,随着结果数据的持续成熟.
研究的目的:
- 审查最近在2022-2023年出版的黑色素瘤全身治疗方面的进展.
- 为外科瘤学家强调关于ICI和BRAF/MEK抑制剂疗法的关键发现,包括辅助和新辅助应用.
主要方法:
- 审查最近发表的临床试验数据和长期随访研究.
- 对全身黑色素瘤治疗的疗效,耐用性和测序策略的分析.
主要成果:
- 长期数据证实了单剂ICI治疗的疗效和耐久性.
- 新的ICI组合疗法显示了增强的疗效;从ICI疗法开始改善了转移性黑色素瘤的生存率.
- 对切除的第三阶段黑色素瘤进行5年辅助治疗的积极结果,以及对IIB/IIC阶段的新数据.
- 一项改变实践的试验证明了可切除宏观黑色素瘤的新辅助疗法改善了结果.
结论:
- 系统性疗法,特别是ICI和BRAF/MEK抑制剂,继续显著改善晚期黑色素瘤的结果.
- 辅助和新辅助策略正在扩大,为切除的疾病阶段提供了更好的结果.
- 治疗的最佳顺序和新兴的组合方法对于最大限度地提高患者的生存和反应耐久性至关重要.
相关概念视频
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...